BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
Public ClinicalTrials.gov record NCT01815450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and efficacy of BLI1100 formulations to placebo for the treatment of moderate to severe acne vulgaris.
Study identification
- NCT ID
- NCT01815450
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 369 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- Oct 31, 2013
- Completion
- Not listed
- Last update posted
- Feb 1, 2015
Started 2013
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Dermatology Clincal Research | Fremont | California | 94538 | — |
| North Florida Dermatology Associates | Jacksonville | Florida | 32204 | — |
| Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| Peachtree Dermatology Associates Research Center | Atlanta | Georgia | 30327 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Clinical Partners | Johnston | Rhode Island | 02919 | — |
| DiscoveResearch | Bryan | Texas | 77802 | — |
| Suzanne Bruce and Associates | Houston | Texas | 77056 | — |
| Dermatology Research Center | Salt Lake City | Utah | 84124 | — |
| The Education and Research Foundation | Lynchburg | Virginia | 24501 | — |
| Women's Clinical Research Center | Seattle | Washington | 98105 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acne Vulgaris trials
Other public records listing Acne Vulgaris. Sorted by last update posted; newest first. Not a recommendation.
- NCT07524946: Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo Recruiting
- NCT06225570: Weekly Isotretinoin vs Tetracycline for Moderate Acne Recruiting
- NCT05891795: Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy Active, not recruiting
- NCT07544251: Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. Recruiting
- NCT02713607: Lipidome and Microbiome Profile of Acne Active, not recruiting
- NCT06425900: A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01815450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2015 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01815450 live on ClinicalTrials.gov.